These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
749 related articles for article (PubMed ID: 27846818)
1. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients. Nissle K; Kopf D; Rösler A BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818 [TBL] [Abstract][Full Text] [Related]
2. Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study. Zhang X; Wang X; Yang J; Liu X; Cai L; Zong Z BMC Infect Dis; 2016 Aug; 16():397. PubMed ID: 27506470 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes. Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543 [TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing. Truong C; Schroeder LF; Gaur R; Anikst VE; Komo I; Watters C; McCalley E; Kulik C; Pickham D; Lee NJ; Banaei N Diagn Microbiol Infect Dis; 2017 Apr; 87(4):365-370. PubMed ID: 28087170 [TBL] [Abstract][Full Text] [Related]
6. Acquisition of Clostridium difficile Colonization and Infection After Transfer From a Veterans Affairs Hospital to an Affiliated Long-Term Care Facility. Ponnada S; Guerrero DM; Jury LA; Nerandzic MM; Cadnum JL; Alam MJ; Donskey CJ Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1070-1076. PubMed ID: 28693636 [TBL] [Abstract][Full Text] [Related]
7. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission. Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648 [TBL] [Abstract][Full Text] [Related]
8. Impact of Toxigenic Clostridium difficile Colonization on the Risk of Subsequent C. difficile Infection in Intensive Care Unit Patients. Tschudin-Sutter S; Carroll KC; Tamma PD; Sudekum ML; Frei R; Widmer AF; Ellis BC; Bartlett J; Perl TM Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1324-9. PubMed ID: 26223207 [TBL] [Abstract][Full Text] [Related]
9. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains. Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988 [TBL] [Abstract][Full Text] [Related]
10. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Leekha S; Aronhalt KC; Sloan LM; Patel R; Orenstein R Am J Infect Control; 2013 May; 41(5):390-3. PubMed ID: 23622704 [TBL] [Abstract][Full Text] [Related]
11. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital. Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676 [TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients. Dubberke ER; Reske KA; Seiler S; Hink T; Kwon JH; Burnham CA Antimicrob Agents Chemother; 2015 Aug; 59(8):4533-43. PubMed ID: 25987626 [TBL] [Abstract][Full Text] [Related]
13. Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012-2014: prospective, repeated cross-sectional study. Furuya-Kanamori L; Clements ACA; Foster NF; Huber CA; Hong S; Harris-Brown T; Yakob L; Paterson DL; Riley TV Clin Microbiol Infect; 2017 Jan; 23(1):48.e1-48.e7. PubMed ID: 27615716 [TBL] [Abstract][Full Text] [Related]
14. Colonization of Toxigenic Mi H; Bao R; Xiao Y; Cui Y; Sun W; Shen Y; Shi Q; Chen X; Lin J; Hu B; Gao X Front Cell Infect Microbiol; 2020; 10():12. PubMed ID: 32083021 [No Abstract] [Full Text] [Related]
15. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities. Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147 [TBL] [Abstract][Full Text] [Related]
16. Validation of Active Surveillance Testing for Clostridium difficile Colonization Using the cobas Cdiff Test. Patel PA; Schora DM; Singh K; Peterson LR J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367295 [No Abstract] [Full Text] [Related]
17. The evaluation of Clostridium difficile infection (CDI) in a community hospital. Daniel A; Rapose A J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221 [TBL] [Abstract][Full Text] [Related]
18. Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients. Blixt T; Gradel KO; Homann C; Seidelin JB; Schønning K; Lester A; Houlind J; Stangerup M; Gottlieb M; Knudsen JD Gastroenterology; 2017 Apr; 152(5):1031-1041.e2. PubMed ID: 28063955 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China. Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]